ArticleTherapeutic advances in gastroenterology2025
Therapeutic preferences of upadacitinib for patients with inflammatory bowel diseases: a nationwide study among Chinese physicians.
Lingya Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.